Eliminating redundancies, increasing efficiency, and cultivating a culture of collaboration were the main themes of a January 19 webinar featuring top U.S. Food and Drug Administration (FDA) officials, hosted by Alliance for a Stronger FDA to discuss the agency’s proposed reorganization.
The U.S. Food and Drug Administration (FDA) announced that Michael C. Rogers has been selected as the permanent Associate Commissioner for Regulatory Affairs in the FDA’s Office of Regulatory Affairs (ORA).
The U.S. Food and Drug Administration’s (FDA’s) proposed reorganization package for a unified Human Foods Program (HFP) and new Office of Regulatory Affairs (ORA) model is now under review at the U.S. Department of Health and Human Services (HHS). The proposed changes have implications that will affect the entire agency.
Namandjé N. Bumpus, Ph.D., current Chief Scientist at the U.S. Food and Drug Administration (FDA), will become the next FDA Principal Deputy Commissioner when Janet Woodcock, M.D. retires in early 2024. One of Dr. Bumpus' main priorities is to assist in the proposed reorganization of a unified Human Foods Program, including creating a new model for the Office of Regulatory Affairs (ORA).
In this episode of Food Safety Matters, we are joined by Sarah Gallo, Vice President of Product Policy at the Consumer Brands Association (CBA). Sarah outlines CBA’s efforts to push for modernization at FDA with regard to inspections, recalls, labeling guidance development, and chemicals management in food packaging. She also shares CBA’s perspective on the proposed reorganization of FDA’s Human Foods Program. Also featured is a conversation with Dr. Emilio Esteban, Under Secretary for Food Safety at the USDA's Office of Food Safety, that was recorded at IAFP 2023 in Toronto, Canada.
